The Michael J. Fox Foundation continually strives to communicate our scientific progress with the research community — through posters and presentations at meetings, in peer-reviewed scientific publications and with white paper reports.
-
The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson's Disease): Design And Methodology (P4.043)
-
Combined Fenobam and Amantadine Treatment Promotes Robust Antidyskinetic Effects in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson's Disease
-
Improving Patient Participation in Parkinson's Clinical Trials: The Experience of The Michael J Fox Foundation
-
Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs
-
A Strategy for the Generation, Characterization and Distribution of Animal Models by The Michael J. Fox Foundation for Parkinson's Research
-
Outcomes Summary -- Regulatory Roundtable for Cognitive Impairment in Parkinson's Disease
-
Articles authored by Rachel Dolhun, MD, a movement disorder specialist on staff at MJFF, offer a practical review of topics related to Parkinson's disease for practicing clinicians.
No results were found.
![Female researcher pipetting in lab.](/sites/default/files/styles/ad_callout_single/public/images/ad/research-news-404---Large-Image-Callout-A-1.jpg?h=ef0d82ac&itok=eyoWusm3)
Breaking Research Updates
Read the latest developments in the field’s understanding and treatment of Parkinson’s disease.